Top

Journal of Gastrointestinal Surgery

Published in:

01-02-2011 | Original Article

The Cholecystokin Provocation HIDA Test: Recreation of Symptoms is Superior to Ejection Fraction in Predicting Medium-Term Outcomes

Authors: Gareth Morris-Stiff, Gavin Falk, Laurel Kraynak, Steven Rosenblatt

Published in: Journal of Gastrointestinal Surgery | Issue 2/2011

Abstract

Background

The ^99m technetium labelled hepato imino diacetic acid (HIDA) scan is widely used in the investigation of patients with typical biliary pain but whose trans-abdominal ultrasound scan (US) is normal. Although the standard measure by which the HIDA scan is deemed positive is the presence of an ejection fraction (EF) of <35% following provocation with cholecystokinin (CCK), there still remains debate as to the usefulness of this measure. The aim of this study was to compare the roles of EF and symptom provocation following CCK infusion in relation to the outcome following laparoscopic cholecystectomy (LC). More specifically, we aimed to review the resolution of symptoms for our significant population of patients with normal HIDA scan EFs for whom surgery has traditionally been deemed inappropriate.

Patients and Methods

All patients undergoing LC for a presumed diagnosis of biliary dyskinesia were identified from a prospectively maintained database. Data were collected regarding pre-operative symptoms, EF and symptom provocation during the CCK HIDA scan, histological findings, early symptomatic outcome, and medium-term follow-up.

Results

During the period from March 2006 to October 2009, 42 patients with biliary symptoms but a negative US were referred for assessment by a single surgeon. There were 31 women and 11 men with a mean age of 39.0 ± 12.6 years. All underwent a CCK HIDA scan of which 17 were positive with an EF <35% and the remaining 25 were negative. All patients reported recreation of symptoms following administration of CCK. All gallbladders were delivered intact for histological assessment and all but one showed evidence of chronic cholecystitis. At each postoperative visit, approximately 2 weeks following the procedure, all patients reported resolution of symptoms. After a mean of 18.7 ± 12.1 months symptom recurrence had been noted in only one of 42 (2.4%).

Conclusions

The CCK HIDA scan is a useful study in the investigation of acalcalous cholecystitis; however, we would suggest that recreation of symptoms following CCK provocation is superior to EF for the identification of underlying chronic cholecystitis. Indeed, a normal gallbladder ejection fraction does not necessarily rule out a biliary aetiology of symptoms for this patient population.

Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377–1390.CrossRefPubMed

Barbara L, Sama C, Morselli Labate AM, et al.Apopulation study on the prevalence of gallstone disease: the Sirmione study. Hepatology 1987; 7: 913–917.CrossRefPubMed

The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. Hepatology 1988; 8: 904–906.

Prevalence of gallstone disease in an Italian adult female population. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Am J Epidemiol 1984; 119: 796–805.

Wistow BW, Subramanian G, Heertum RL, et al. An evaluation of 99mTc-labeled hepatobiliary agents. J Nucl Med 1977; 18:455–461.PubMed

Ryan J, Coope Mm Loberg M, Harvey E, Sikorski S. Technetium-99 m-labelled N-(2,6-Dimethylphenylcarbamoylmethyl) iminodiacetic acid (Tc-99 m HIDA): a new radiopharmaceutical for hepatobiliary imaging studies. J Nucl Med 1977; 18: 995–1002.

Krishnamurthy GT, Bobba VR, Kingston E. Radionuclide ejection fraction: a technique for quantitative analysis of motor function of the human gallbladder. Gastroenterology 1981; 80: 482–490.PubMed

Rastogi A, Slivka A, Moser AJ, et al. Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain. Dig Dis Sci 2005; 50: 1391–1401.CrossRefPubMed

Krishnamurthy GT, Brown PH. Comparison of fatty meal and intravenous cholecystokinin Infusion for gallbladder ejection fraction. J Nucl Med 2002; 43: 1603–1610.PubMed

10.

Yap L, Wycherley AG, Morphett AD, et al. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology 1991; 101: 786–793.PubMed

11.

Ziessman HA, Fahey FH, Hixson DJ. Calculation of a gallbladder ejection fraction: advantage of continuous sincalide infusion over the three-minute infusion method. J Nucl Med 1992; 33: 537–541.PubMed

12.

Pickleman J, Peiss RL, Henkin R. The role of sinaclide cholecscintigraphy in the evaluation of patients with acalcalous gallbladder disease. Arch Surg 1985; 120: 693–697.PubMed

13.

Fick-Bennett D, DeRidder P, Kolozsi WZ, et al. Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chronic acalculous gallbladder disease. J Nucl Med 1991; 32: 1695–1699.

14.

Misra DC Jr, Blossom GB, Fink-Bennett D, et al. Results of surgical therapy for biliary dyskinesia. Arch Surg 1991; 126: 957–960.PubMed

15.

Zech Er, Simmons LB, Kendrick RR, et al. Cholecystokinin enhanced hepatobiliary scanning with ejection fraction calculation as an indicator of disease of the gallbladder. Gynecol Obstet Surg 1991; 172: 21–24.

16.

Reed DN Jr, Fernandez M, Hicks RD. Kinevac-assisted cholescintigraphy as an accurate predictor of chronic acalcalous gallbladder disease and the likelihood of symptom relief with cholecystectomy. 1993; Am Surg 59: 273–277.PubMed

17.

Sorenson MK, Fancher S, Lang NP, et al. Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesia. Am J Surg 1993; 166: 672–674.CrossRefPubMed

18.

Watson A, Better N, Kalff V, Nottle P, Scelwyn M, Kelly MJ. Cholecystokinin (CCK)-HIDA scintigraphy in patients with suspected gallbladder dysfunction. Austr Radiol 1994; 39: 30–33.CrossRef

19.

Barron LG, Rubio PA. Importance of accurate preoperative diagnosis and the role of advanced laparoscopic cholecystectomy in relieving chronic acalcalous cholecystitis. J Laparoendosc Surg 1995; 5: 357–361.PubMed

20.

Khosla R, Singh A, Miedema BW, et al. Cholecystectomy alleviates acalculous biliary pain in patients with a reduced gallbladder ejection fraction. South Med J 1997; 90: 1087–1090.CrossRefPubMed

21.

Canfield AJ, Hetz SP, Schriver JP, et al. Biliary dyskinesis: a study of more than 200 patients and review of the literature. Gastrointest Surg 1998; 2: 443–448.CrossRef

22.

Klieger PS, O’Mara RE. The clinical utility of quantitative cholecyscintigraphy: the significance of gallbladder dysfunction. Abstr Clin Nucl Med 1998; 23: 278–282.CrossRef

23.

Yost F, Margenthaler J, Presti M, et al. Cholecystectomy is an effective treatment for biliary dyskinesia. Am J Surg 1999; 178: 462–465.CrossRefPubMed

24.

Skipper K, Sligh S, Dunn E, Schwartz A. Laparoscopic cholecystectomy for an abnormal hepato-iminodiacetic acid scan: a worthwhile procedure? Am Surg 2000; 66: 30–32.PubMed

25.

Chen PF, Nimeri A, Pham QH, et al. The clinical diagnosis of chronic acalculous cholecystitis. Surgery 2001; 130: 578–581.CrossRefPubMed

26.

Middleton GW, Williams JH. Diagnostic accuracy of 99Tcm-HIDA with cholecystokinin and gallbladder ejection fraction in acalculous gallbladder disease. Nucl Med Commun 2001; 22: 657–661.CrossRefPubMed

27.

Poynter MT, Saba AK, Evans RA, et al. Chronic acalculous biliary disease: cholecystokinin cholescintigraphy is useful in formulating treatment strategy and predicting success after cholecystectomy. Am Surg 2002; 68: 382–384.PubMed

28.

Majeski J. Gallbladder ejection fraction: an accurate evaluation of symptomatic acalculous gallbladder disease. Int Surg 2003; 88: 95–99.PubMed

29.

Ponsky TA, DeSagun R, Brody F. Surgical therapy for biliary dyskinesia: a meta-analysis and review of the literature. J Laparoendosc Adv Surg Tech 2005; 15: 239–242.

30.

Riyad K, Chalmers CR, Aldouri A, et al. The role of 99mtechnetium-labelled hepato imino diacetic acid (HIDA) scan in the management of biliary pain. HPB 2007; 9: 219–224.CrossRefPubMed

31.

Sabbaghian MH, Rich BS, Rothberger GD, et al. Evaluation of surgical outcomes and gallbladder characteristics in patients with biliary dyskinesia. J Gastrointest Surg 2008; 12: 1224–1230.CrossRef

32.

Paajanen H, Miilunpohja S, Joukainen S, Heikkinen J. Role of quantitative cholescintigraphy for planning laparoscopic cholecystectomy in patients with gallbladder dyskinesia and chronic abdominal pain. Surg Laparosc Endosc Percutan Tech 2009; 19: 16–19.CrossRefPubMed

33.

Westlake PJ, Hershfield NB, Kelly JK, et al. Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol 1990; 85: 986–990.PubMed

34.

Jones DB, Soper NJ, Brewer JD, et al. Chronic acalcalous cholecystitis: laparoscopic treatment. Surg Laparosc Endosc 1996; 6: 114–122.CrossRefPubMed

35.

Mishkind MT, Pruitt RF, Bambini DA, et al. Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease. Am Surg 1997; 63: 769–774.PubMed

36.

Adams DB, Tarnasky PR, Hawes RH, et al. Outcome after laparoscopic cholecystectomy for chronic acalculous cholecystitis. Am Surg 1998; 64: 1–5.PubMed

37.

Goncalves RM, Harris JA, Rivera DE. Biliary dyskinesia: natural history and surgical results. Am Surg 1998; 64: 493–497.PubMed

38.

Smythe A, Majeed AW, Fitzhenry M, et al. A requiem for the cholecystokinin provocation test? Gut 1998; 43: 571–574.CrossRefPubMed

39.

Cunningham CC, Sehon JK, Johnson LW, Zibari GB. Outcomes of surgical therapy for biliary dyskinesia. J La State Med Soc 2003; 155: 189–191.PubMed

40.

Delgado-Aros S, Cremonini F, Bredenoord AJ, et al. Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain? Aliment Pharmacol Ther 2003; 18: 167–174.CrossRefPubMed

41.

DiBaise JK, Oleynikov D. Does gallbladder ejection fraction predict outcome after cholecystectomy for suspected chronic acalculous gallbladder dysfunction? A systematic review. Am J Gastroenterol 2003; 98: 2605–2611.CrossRefPubMed

42.

Ozden N, DiBaise JK. Gallbladder ejection fraction and symptom outcome in patients with acalculous biliary-like pain. Dig Dis Sci 2003; 48: 890–897.CrossRefPubMed

43.

Young SB, Arregui M, Singh K. HIDA scan ejection fraction does not predict sphincter of Oddi hypertension or clinical outcome in patients with suspected chronic acalculous cholecystitis. Surg Endosc 2006; 20: 1872–1878.CrossRefPubMed

44.

Geiger TM, Awad ZT, Burgard M, et al. Prognostic indicators of quality of life after cholecystectomy for biliary dyskinesia. Am Surg 2008; 74: 400–404.PubMed

45.

Carr JA, Walls, MA, LJ Bryan, DL Snider. The treatment of gallbladder dyskinesia based upon symptoms: results of a 2-year, prospective, nonrandomized, concurrent cohort study. Surg Laparosc Endosc Percutan Tech 2009; 19: 222–226.CrossRefPubMed

46.

Rhodes M, Lennard TW, Farndon JR, Taylor RM. Cholecystokinin (CCK) provocation test: long-term follow-up after cholecystectomy. Br J Surg 1988; 75: 951–953.CrossRefPubMed

47.

Sunderland GT, Carter DC. Clinical application of the cholecystokinin provocation test. Br J Surg 1988; 75: 444–449.CrossRefPubMed

48.

Gunna BR, Yannam GR, Kavita N, Pathak S, Alla BR. Acalculous biliary tract disorders: the value of fatty meal-cholescintigraphy. Surgeon; 1: 293–295.

49.

Hadigan C, Fishman SJ, Connolly LP, Treves ST, Nurko S. Stimulation with fatty meal (Lipomul) to assess gallbladder emptying in children with chronic acalculous cholecystitis. J Pediatr Gastroenterol Nutr 2003; 37: 178–182.CrossRefPubMed

50.

Velanovich V. Biliary dyskinesia and biliary crystals: a prospective study. Am Surg 1997; 63: 69–74.PubMed

51.

Krishnamurthy GT, Krishnamurthy S, Brown PH. Constancy and variability of gallbladder ejection fraction: impact on diagnosis and therapy. J Nucl Med 2004; 45: 1872–1877.PubMed

52.

Williams I, Slavin G, Cox A, Simpson P, de Lacey G. Diverticular disease (adenomyomatosis) of the gallbladder: a radiologicalpathological survey. Br J Radiol 1986; 59: 29–34.CrossRefPubMed

53.

Poonam Y, Ashu S, Rohini G. Clinics in diagnostic imaging (121). Singapore Med J 2008; 49: 262–265.PubMed

54.

Nabatame N, Shirai Y, Nishimura A, et al. High risk of gallbladder carcinoma in elderly patients with segmental adenomyomatosis of the gallbladder. J Exp Clin Cancer Res 2004; 23: 593–598.PubMed

Title: The Cholecystokin Provocation HIDA Test: Recreation of Symptoms is Superior to Ejection Fraction in Predicting Medium-Term Outcomes
Authors: Gareth Morris-Stiff
Gavin Falk
Laurel Kraynak
Steven Rosenblatt
Publication date: 01-02-2011
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 2/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-010-1342-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Cholecystokin Provocation HIDA Test: Recreation of Symptoms is Superior to Ejection Fraction in Predicting Medium-Term Outcomes

Abstract

Background

Patients and Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Patients and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2011

Therapeutic Efficacy of Combined Intraoperative Ablation and Resection for Colorectal Liver Metastases: An International, Multi-institutional Analysis

Improvement of Respiratory Symptoms Following Heller Myotomy for Achalasia

Management and Outcome of Intrathoracic Bleeding due to Vascular Injury During Transhiatal Esophagectomy

A Novel Technique of Partial Splenectomy Using Radiofrequency Ablation

An Analysis of the Utility of Handheld PET Probes for the Intraoperative Localization of Malignant Tissue

Solid Pseudopapillary Tumors of the Pancreas. Clinical Features, Surgical Outcomes, and Long-Term Survival in 45 Consecutive Patients from a Single Center